Intermittent hypoxia and insulin resistance in OSAHS patients can promote the increase of inflammatory markers, including nitric oxide (NO), endothelin-1(ET-1), interleukin-6 (IL-6), and C-reactive protein (CRP). This evidence concerns the gene EDN1 and obstructive sleep apnea syndrome.